PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results
June 16, 2025 19:20 ET | Source: PolyPid Ltd. The Company Anticipates…
Dr. Elad Yossefi and Dr. Tal Yossefi Introduce Tech-Enhanced Dental Services in Norwalk
Norwalk, CT / USA, June 16, 2025 (GLOBE NEWSWIRE) -- Norwalk, CT…
Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results
June 16, 2025 18:40 ET | Source: Enzo Biochem, Inc. FARMINGDALE, N.Y.,…
OTOFIX Introduces the D1 Lite Diagnostic Tool, Purpose-Built for Small Garage Technicians
Shenzhen, China, June 16, 2025 (GLOBE NEWSWIRE) -- OTOFIX has just introduced the D1…
Power Queen’s Father’s Day Hot Battery Offer Opens for a Limited Time
Shenzhen, China, June 16, 2025 (GLOBE NEWSWIRE) -- To Celebrate the Father's Day,…
Kaleris and Port of Tanjung Pelepas Recognized for Advancement Optimization With 2025 Top Supply Chain Projects Award
ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Kaleris, a leading provider of…
Roche to advance prasinezumab into Phase III development for early-stage Parkinson’s disease
Results from Phase IIb PADOVA and longer term follow-up data suggest clinical…
EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL
ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage…
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal…
XRP News: Vaultro Finance Presale on XRP ledger Skyrockets Past 50%, As Investors Race to Own $VLT Token
SINGAPORE , June 15, 2025 (GLOBE NEWSWIRE) -- Vaultro Finance has just…
